Leroux-Roels, Geert <br/><br/>
Safety, reactogenicity and immunogenicity of a novel pneumococcal protein-based vaccine in adults: a phase I/II randomized clinical study.  [electronic resource] 

 -  Vaccine  Nov 2014 
 - 6838-46 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1873-2518 
<br/><br/><label>Standard No.: </label>10.1016/j.vaccine.2014.02.052  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Antibodies, Bacterial--blood<br/>Bacterial Proteins--immunology<br/>Double-Blind Method<br/>Drug-Related Side Effects and Adverse Reactions--epidemiology<br/>Female<br/>Healthy Volunteers<br/>Humans<br/>Hydrolases--immunology<br/>Male<br/>Placebos--administration & dosage<br/>Pneumococcal Vaccines--administration & dosage<br/>Streptococcus pneumoniae--immunology<br/>Streptolysins--immunology<br/>Vaccination--adverse effects<br/>Young Adult